Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Metabolites ; 14(4)2024 Mar 29.
Article in English | MEDLINE | ID: mdl-38668321

ABSTRACT

Hepatic encephalopathy (HE) is a major neuropsychological condition that occursas a result of impaired liver function. It is frequently observed in patients with advanced liver disease or cirrhosis. Memory impairment is among the symptoms of HE; the pathophysiologic mechanism for this enervating condition remains unclear. However, it is possible that neuroinflammation may be involved, as recent studies have emphasized such phenomena. Therefore, the aim of the present study is to assess short working memory (SWM) and examine the involvement of microglia in a chronic model of HE. The study was carried out with male Wistar rats that were induced by repeated thioacetamide (TAA) administration (100 mg/kg i.p injection for 10 days). SWM function was assessed through Y-maze, T-Maze, and novel object recognition (NOR) tests, together with an immunofluorescence study of microglia activation within the hippocampal areas. Our data showed impaired SWM in TAA-treated rats that was associated with microglial activation in the three hippocampal regions, and which contributed to cognitive impairment.

2.
Acta Neurobiol Exp (Wars) ; 83(2): 203-215, 2023.
Article in English | MEDLINE | ID: mdl-37493536

ABSTRACT

Hepatic encephalopathy (HE) is a neuropsychiatric hepatic­induced syndrome in which several factors are involved in promoting brain perturbations, with ammonia being the primary factor. Motor impairment, incoordination, and gut dysbiosis are some of the well­known symptoms of HE. Nevertheless, the link between the direct effect of hyperammonemia and associated gut dysbiosis in the pathogenesis of HE is not well established. Thus, this work aimed to assess motor function in hyperammonemia and gut dysbiosis in mice. Twenty­eight Swiss mice were distributed into three groups: two­week and four­week hyperammonemia groups were fed with an ammonia­rich diet (20% w/w), and the control group was pair­fed with a standard diet. Motor performance in the three groups was measured through a battery of motor tests, namely the rotarod, parallel bars, beam walk, and static bars. Microbial analysis was then carried out on the intestine of the studied mice. The result showed motor impairments in both hyperammonemia groups. Qualitative and quantitative microbiological analysis revealed decreased bacterial load, diversity, and ratios of both aerobic and facultative anaerobic bacteria, following two and four weeks of ammonia supplementation. Moreover, the Shannon diversity index revealed a time­dependent cutback of gut bacterial diversity in a treatment­time­dependent manner, with the presence of only Enterobacteriaceae, Streptococcaceae, and Enterococcaceaeat at four weeks. The data showed that ammonia­induced motor coordination deficits may develop through direct and indirect pathways acting on the gut­brain axis.


Subject(s)
Gastrointestinal Microbiome , Hepatic Encephalopathy , Hyperammonemia , Mice , Animals , Hepatic Encephalopathy/complications , Hepatic Encephalopathy/metabolism , Brain-Gut Axis , Dysbiosis/complications , Hyperammonemia/complications , Hyperammonemia/metabolism , Ammonia/toxicity
3.
Heliyon ; 8(1): e08799, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35071819

ABSTRACT

The newly emerged 2019 coronavirus disease (COVID-19) has urged scientific and medical communities to focus on epidemiology, pathophysiology, and treatment of SARS-CoV-2. Indeed, little is known about the virus causing this severe acute respiratory syndrome pandemic, coronavirus (SARS-CoV-2). Data already collected on viruses belonging to the coronaviridae family are of interest to improve our knowledge rapidly on this pandemic. The current review aims at delivering insight into the fundamental advances inSARS-CoV-2 epidemiology, pathophysiology, life cycle, and treatment.

4.
Biomed Res Int ; 2021: 9998420, 2021.
Article in English | MEDLINE | ID: mdl-34527748

ABSTRACT

The global burden of viral infection, especially the current pandemics of SARS-CoV-2, HIV/AIDS, and hepatitis, is a very risky one. Additionally, HCV expresses the necessity for antiviral therapeutic elements. Venoms are known to contain an array of bioactive peptides that are commonly used in the treatment of various medical issues. Several peptides isolated from scorpion venom have recently been proven to possess an antiviral activity against several viral families. The aim of this review is to provide an up-to-date overview of scorpion antiviral peptides and to discuss their modes of action and potential biomedical application against different viruses.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Peptides/pharmacology , Scorpion Venoms/chemistry , Virus Diseases/drug therapy , Animals , Coronavirus/drug effects , HIV-1/drug effects , Hepatitis Viruses/drug effects , Herpesvirus 1, Human/drug effects , Humans , Measles virus/drug effects , Peptides/chemistry , Peptides/isolation & purification , Virus Diseases/virology
5.
C R Biol ; 343(1): 101-110, 2020 Jun 05.
Article in English | MEDLINE | ID: mdl-32720492

ABSTRACT

Dehydroepiandrosterone sulfate (DHEAS) exerts important functions in the nervous system, such as modulation of neuronal death, brain development, cognition and behavior. However, little is known about the possible interactions of this steroid with the glial cells, in particular those forming circumventricular organs (CVOs). The present study, on the one hand, was focused on the assessment of the possible effect of DHEAS on the subcommissural organ in rats. Known as one of the CVOs, the SCO can release a glycoprotein of high molecular weight named Reissner's fiber (RF) into the cerebrospinal fluid (CSF), a remarkable secretory activity. On the other hand, we examined the serotonergic innervation in the Dorsal Raphe nucleus (DRN) and the subsequent SCO. Our finding has revealed a significant increase in RF immunoreactivity within the SCO following a single i.p injection of DHEAS at a dose of 5 mg/kg B.W. A loss of serotonin (5-HT) within the DRN and fibers reaching the SCO was also observed. The present findings have brought evidence of a possible modulator potential of neurosteroids, in particular DHEAS, upon the secretory activity of the SCO. This study will open a new window for a better understanding of the main role and interaction of neurosteroids with one of the relevant circumventricular organs in the mammalian brain.


La Dehydroépiandrostérone sulfate (DHEAS) exerce des fonctions importantes dans le système nerveux central comme la modulation de la mort neuronale, le développement du cerveau, la cognition et le comportement. Cependant, très peu est connu concernant l'interaction de cette stéroïde avec les cellules gliales, en particulier celles formant les organes circumventriculaires (CVOs). La présente étude, d'une part, s'est focalisée sur l'évaluation du possible effet de la DHEAS sur l'organe sous commissural (SCO) chez le rat connu en tant qu'un des CVOs. L'organe sous commissural peut libérer une glycoprotéine de grand poids moléculaire nommée fibre de Reissner (RF) dans le liquide céphalorachidien (CSF) ; une activité sécrétoire remarquable. D'autre part, nous avons examiné l'innervation sérotoninérgique du noyau de Raphé dorsal (DRN) et l'éventuelle innervation du SCO. Nos données ont révélé une élévation significative de l'immunoréactivité à la RF dans le SCO après une seule injection i.p de la DHEAS à une dose de 5mg/kg B.W. une réduction de sérotonine (5-HT) dans le DRN et les fibres atteignant le SCO a été aussi observée. Les présentes données ont apporté une évidence d'un possible potentiel modulateur des neurostéroïdes, en particulier la DHEAS sur l'activité sécrétoire du SCO. Cette étude pourra ouvrir une nouvelle fenêtre pour une meilleure compréhension du rôle et de l'interaction des neurostéroïdes avec un des organes circumventriculaires les plus importants du cerveau des mammifères.


Subject(s)
Dehydroepiandrosterone Sulfate/metabolism , Dorsal Raphe Nucleus/physiology , Neurosteroids/metabolism , Animals , Cell Adhesion Molecules, Neuronal/metabolism , Immunohistochemistry , Male , Rats , Rats, Sprague-Dawley , Serotonin/physiology , Subcommissural Organ/metabolism
6.
J Chem Neuroanat ; 106: 101789, 2020 07.
Article in English | MEDLINE | ID: mdl-32334030

ABSTRACT

This study examined the effect of prolonged water deprivation, in rat, on 5-HT and TH- immuno-expression in Dorsal Raphe Nucleus (DRN), Substantia Nigra pars compacta (SNc), Ventral Tegmental Area (VTA), and Magnus Raphe Nucleus (MRN). In parallel, we evaluated the anxiety state and pain perception in dehydrated rats. Our Findings revealed that dehydrated rats exhibited more preference for the dark compartment, suggesting that prolonged water deprivation is associated to an anxiogenic effect. After one week, 5 H T IR in the DRN of dehydrated rates showed a significant decrease. This was reversed to a significant increase post week 2 of dehydration. Our findings also demonstrated that TH-IR in DRN, MRN, SNc and VTA neuronal systems is significantly and gradually enhanced after 1-and-2-week osmotic stress. In addition, our results proved that all dehydrated rats were characterized by a significant and proportional rise of the reaction time to the nociceptive response in the hot plate test, as water deprivation duration increased, suggesting that dehydration caused a significant decrease in pain perception. Finally, the data described here clearly showed the implication of serotonin and dopamine neurotransmitter systems in the resistance to osmotic stress. Therefore, in this study, such central impairments were traduced by a few peripheral outcomes manifested by changes in mood state and nociception.


Subject(s)
Anxiety/metabolism , Pain Perception/physiology , Serotonin/metabolism , Tyrosine 3-Monooxygenase/metabolism , Water Deprivation/physiology , Animals , Anxiety/physiopathology , Behavior, Animal/physiology , Dorsal Raphe Nucleus/metabolism , Dorsal Raphe Nucleus/physiopathology , Male , Nucleus Raphe Magnus/metabolism , Nucleus Raphe Magnus/physiopathology , Osmotic Pressure/physiology , Pars Compacta/metabolism , Pars Compacta/physiopathology , Rats , Rats, Wistar , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/physiopathology
7.
J Chem Neuroanat ; 102: 101686, 2019 12.
Article in English | MEDLINE | ID: mdl-31562917

ABSTRACT

Manganese (Mn) is an essential metallic trace element involved in several vital biological functions. Conversely, exposure to excessive levels of Mn induces manganism, causing neurodegeneration and symptoms similar to those seen in Parkinson's disease (PD). Docosahexaenoic acid (DHA) is a long-chain polyunsaturated fatty acid exhibiting neuroprotective properties against neurodegenerative diseases and brain injuries and is known to easily incorporate into membrane phospholipids of brain cells and meditates its corrective actions. In the present study, mice were used for a sub-acute Mn intoxication model to investigate DHA neuroprotective potential against Mn neurotoxicity. We also seek to understand the mechanism by which Mn intoxication induces these motor impairments at 30 mg/kg, by pretreatment with DHA at 200 mg/kg and assessment of changes in spontaneous locomotor behavior by open field test (OF), motor coordination using the rotarod test (RR) and strength by mean of weights test (WT). To highlight these effects on brain neurotransmission, we evaluated the tyrosine hydroxylase immunoreactivity (TH-IR) within substantia nigra compacta (SNC) and striatum (St). Results showed that Mn intoxication significantly altered motor behavior parameters including, decreased of traveled distance by 46%, decreased mean speed by 36%, reduced the ability to sustain the rotarod test to 42%; Moreover, a drop score was obtained using weights test and reflecting affected strength in Mn-intoxicated animals. Pretreatment by DHA prevents mice from Mn toxicity and maintain normal spontaneous activity, motor coordination and strength. Data also showed the ability of Mn to disrupt dopamine neurotransmission by altering tyrosine hydroxylase activity in the nigrostriatal pathway while in pretreated animals, DHA prevented this disruption. Data approved the potential neurotoxic effect of Mn as a risk factor of the Parkinsonism onset, and then demonstrated for the first time the neuroprotective and nutraceutical outcomes of DHA in the sub-acute Mn-intoxication animal model.


Subject(s)
Docosahexaenoic Acids/therapeutic use , Dopamine/metabolism , Locomotion/drug effects , Manganese Poisoning/drug therapy , Motor Activity/drug effects , Neuroprotective Agents/therapeutic use , Animals , Behavior, Animal/drug effects , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Disease Models, Animal , Docosahexaenoic Acids/pharmacology , Male , Manganese/toxicity , Mice , Neuroprotective Agents/pharmacology , Pars Compacta/drug effects , Pars Compacta/metabolism , Rotarod Performance Test , Synaptic Transmission/drug effects , Tyrosine 3-Monooxygenase/metabolism
8.
Brain Res Bull ; 150: 307-316, 2019 08.
Article in English | MEDLINE | ID: mdl-31228545

ABSTRACT

Studying the non-motor disorders of the prodromal phase of Parkinson's disease (PD) is of great importance because of their negative impact on patient's quality of life. Classical neurotoxic animal models of PD generally unable the exploration of the progression of the non-motor phase of the prodromal stage of the disease. The aim of this study is to assess the evolution of two types of memory alteration namely; short working and spatial memories at different stages of the prodromal phase of a rat model of PD, using repetitive reserpine administration at low dose. The study was carried out in rat with repeated i.p reserpine administration (0.2 mg/kg/day) during 13 days. Working memory was assessed by the Novel Object Recognition test (NOR) and the T-maze, while spatial memory was assessed by Morris Water maze (MWM) at to stages (7days and 13days) of prodromal phase of the disease. By means of immunohistochemistry, the serotonergic innervation of the Baso-Lateral Amygdala nucleus (BLA) as well as the morphological changes of astroglia within hippocampus (using anti-GFAP marker) were examined at the latest stage (13days) of the disease. Our data show a differential deterioration of short-term working memory without the long-term spatial memory being changed which was accompanied by a significant decrease in serotonin innervation of the BLA and a striking change in both density and morphology of the astrocyte at the level of the hippocampus. The present study has brought evidence of an early deficit of short working memory rather than spatial memory deficit which seems to be intact even at the latest stage of the prodromal phase of PD. Such deficit could arise from the loss of 5-HT innervation in BLA and/or the astroglial morpho-functional changes within the hippocampus leading to possible neurophysiological disturbances of the different neighboring neuronal populations involved in short working memory.


Subject(s)
Memory, Short-Term/physiology , Spatial Memory/physiology , Amygdala/physiopathology , Animals , Astrocytes/pathology , Brain/physiopathology , Disease Models, Animal , Hippocampus/physiopathology , Male , Memory Disorders/physiopathology , Parkinson Disease/physiopathology , Prefrontal Cortex/physiopathology , Prodromal Symptoms , Quality of Life , Rats , Reserpine/pharmacology , Visual Perception
9.
Behav Brain Res ; 367: 201-209, 2019 07 23.
Article in English | MEDLINE | ID: mdl-30928460

ABSTRACT

Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome resulting from acute or chronic hepatic impairments. The clinical features of HE include attention as well as a mild cognitive deficits associated with impaired attentional and executive networks in patients as well as in animal models of HE. The underlining pathomechanism of memory impairment in HE patients is still not fully understood; however, it may involve a possible gliopathy as well as neuropathy. The aim of the present investigation is to assess progression of short working memory deterioration in acute HE and to delineate the glial and the neuronal alteration which may underlie such cognitive impairment. The study was carried out in male Sprague-Dawley rats with acute liver failure induced by thioacetamide (TAA). The study was performed on different stages of acute HE; 12 h, 24 h and 36 h following administration of TAA. The liver functions were assessed via different biochemical markers (ALT, AST, bilirubin, urea and creatinine) and an histopathological examination of the liver tissue. While for the behavioral study, we used T-Maze test to assess short working memory using the percentage of alternation behavior, together with an immunohistochemical analysis of the Glial Fibrillary Acidic Protein (GFAP) as the key marker of astrocytes in the hippocampus, as well as serotonin (5-HT) for 5-HTergic neurons within the dorsal Raphe nucleus (DRN). Our data revealed a progressive loss of liver tissue integrity with inflammation and hepatocytes degeneration which was associated to obvious loss of the liver function. In parallel, we observed a gradual alteration of the alternation behavior, as a sign of altered short working memory in the acute HE rats. At the central level, the immunohistochemical study showed a time dependent region-specific changes of GFAP-immunoreactive astrocytes within the hippocampus. While within the DRN, serotonin levels declined progressively in a time-dependant manner. Our data revealed for the first time, a gradual loss of short memory function in acute HE, resulting from liver dysfunction. Such cognitive deterioration may involve a possible gliopathy as well as a 5-HTergic dysfunction which could be considered as a new key element for understanding the basis of memory and attention loss in HE patients.


Subject(s)
Cognitive Dysfunction/physiopathology , Dorsal Raphe Nucleus , Hepatic Encephalopathy/physiopathology , Hippocampus , Maze Learning/physiology , Memory, Short-Term/physiology , Animals , Cognitive Dysfunction/etiology , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/pathology , Disease Models, Animal , Dorsal Raphe Nucleus/metabolism , Dorsal Raphe Nucleus/pathology , Dorsal Raphe Nucleus/physiopathology , Hepatic Encephalopathy/complications , Hepatic Encephalopathy/metabolism , Hepatic Encephalopathy/pathology , Hippocampus/metabolism , Hippocampus/pathology , Hippocampus/physiopathology , Male , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...